CRVS
Corvus Pharmaceuticals, Inc. ยท Health Care ยท NASDAQ
$12.56
โฒ $0.65 (+5.46%)
Market cap
$1.0B
52-week range
$3.55 โ $26.95
Volume
1.4M
Previous close
$11.91
Corvus Pharmaceuticals, Inc. (CRVS) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: ORBIMED ADVISORS LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
2.1% | 7.2M | $105M | โ | $0.91 | 2026-03-31 |
| Deep Track Capital, LP Deep Track Capital, LP |
0.6% | 2.5M | $36M | NEW (+2.5M) | $14.63 | 2026-03-31 |
FAQ โพ
Which hedge funds hold CRVS?
Tracked holders include: ORBIMED ADVISORS LLC, Deep Track Capital, LP.
How much smart money owns CRVS?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading CRVS?
No tracked Congressional trades in CRVS on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.